Nutex Health Inc.
NUTX
$123.54
-$16.97-12.08%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 269.77% | 25.62% | 29.12% | 19.75% | 29.68% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 269.77% | 25.62% | 29.12% | 19.75% | 29.68% |
| Cost of Revenue | 113.84% | 1.95% | 8.60% | 11.84% | -3.72% |
| Gross Profit | 720.89% | 127.64% | 96.10% | 62.23% | 38,257.78% |
| SG&A Expenses | 200.20% | 50.80% | 5.81% | -4.05% | 271.40% |
| Depreciation & Amortization | 12.77% | 4.77% | 8.72% | 4.82% | 43.12% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 118.65% | 8.20% | 8.14% | 8.99% | 10.23% |
| Operating Income | 2,701.30% | 1,396.99% | 3,402.10% | 134.29% | 170.54% |
| Income Before Tax | 453.56% | 46.97% | 176.82% | 98.05% | -246.87% |
| Income Tax Expenses | 387.09% | 1,439.32% | 209.60% | 142.79% | -266.11% |
| Earnings from Continuing Operations | 460.75% | -58.38% | 170.56% | 92.16% | -159.99% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -879.74% | -59.38% | -528.54% | -89.95% | 4.57% |
| Net Income | 295.13% | -58.56% | 89.54% | 92.93% | -114.33% |
| EBIT | 2,701.30% | 1,396.99% | 3,402.10% | 134.29% | 170.54% |
| EBITDA | 663.23% | 994.45% | 1,015.39% | 225.45% | 422.67% |
| EPS Basic | 257.73% | -37.84% | 90.78% | 93.67% | -150.00% |
| Normalized Basic EPS | 667.71% | 35.96% | 219.27% | 102.49% | 48.97% |
| EPS Diluted | 248.10% | -37.84% | 90.78% | 91.67% | -130.59% |
| Normalized Diluted EPS | 633.64% | 35.96% | 219.27% | 102.49% | 48.97% |
| Average Basic Shares Outstanding | 23.71% | 15.03% | 13.54% | 11.75% | -14.27% |
| Average Diluted Shares Outstanding | 31.61% | 15.03% | 13.54% | 11.75% | -14.27% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -3.43% | -- |